Tag Archives: Christopher Contag

What level of risk will be tolerated for interventions that are developed for treating “pre-diseased” patients?

Crossing the Biology to Pathobiology Threshold: Distinguishing Precision Health from Precision Medicine Event Flyer Diseases have long been defined by their symptoms, and therefore patients have typically been treated when they are symptomatic. However, through advances in “omics,” wearable sensors, … Continue reading

Posted in Bioethics Events, Brownbag & Webinar Series, Outreach, Public Seminar Series | Tagged , , , , , , , | Comments Off on What level of risk will be tolerated for interventions that are developed for treating “pre-diseased” patients?